EVP R&D, Chief Medical Officer
Mon, Nov 11, 2024
Nov 11
58,996 shares @ $30.08
Decreased holdings by -41.50%
7th largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 13% above 200-day moving average